Filings under KG by King Pharmaceuticals Inc (CIK 0001047699) from Jan 11, 2006 to Jan 31, 2011 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Cohen Erik | Director | Grant(A) | 6K | — | $0 |
| Jun 10, 2026 | Brecher Joseph | Director | Grant(A) | 6K | — | $0 |
| Jun 10, 2026 | Hotchkiss Michael | Director | Grant(A) | 6K | — | $0 |
| Jun 10, 2026 | Weissmann Jeffrey | Director | Grant(A) | 6K | — | $0 |
| Jun 10, 2026 | Nigro Steven Harold | Director | Grant(A) | 6K | — | $0 |
| Mar 18, 2026 | Ledbetter Terry Lee | Executive Chairman, Director, 10% Owner | Grant(A) | 97K | — | $0 |
| Mar 18, 2026 | Ledbetter Terry Lee | Executive Chairman, Director, 10% Owner | Grant(A) | 49K | — | $0 |
| Mar 18, 2026 | Ledbetter Terry Lee | Executive Chairman, Director, 10% Owner | Disposed to issuer(D) | 13K | $9.96 | $127K |
| Mar 18, 2026 | Ledbetter Bradford Luke | Chief Executive Officer, Director, 10% Owner | Grant(A) | 49K | — | $0 |
| Mar 18, 2026 | Ledbetter Bradford Luke | Chief Executive Officer, Director, 10% Owner | Grant(A) | 97K | — | $0 |
| Mar 18, 2026 | Ledbetter Bradford Luke | Chief Executive Officer, Director, 10% Owner | Tax withholding(F) | 13K | $9.96 | $127K |
| Mar 18, 2026 | Haveron Patrick J | President and CFO | Tax withholding(F) | 13K | $9.96 | $127K |
| Mar 18, 2026 | Haveron Patrick J | President and CFO | Grant(A) | 97K | — | $0 |
| Mar 18, 2026 | Haveron Patrick J | President and CFO | Grant(A) | 49K | — | $0 |
| Mar 14, 2026 | Haveron Patrick J | President and CFO | Tax withholding(F) | 7K | $10.48 | $70K |
| Sep 5, 2025 | Weissmann Jeffrey | Director | Grant(A) | 2K | — | $0 |
| Sep 5, 2025 | Nigro Steven Harold | Director | Grant(A) | 2K | — | $0 |
| Sep 5, 2025 | Cohen Erik | Director | Grant(A) | 2K | — | $0 |
| Sep 5, 2025 | Brecher Joseph | Director | Grant(A) | 2K | — | $0 |
| Sep 5, 2025 | Hotchkiss Michael | Director | Grant(A) | 2K | — | $0 |
| May 27, 2025 | Brecher Joseph | Director | Grant(A) | 6K | — | — |
| May 27, 2025 | Haveron Patrick J | President and CFO | Grant(A) | 127K | — | — |
| May 27, 2025 | Haveron Patrick J | President and CFO | Grant(A) | 17K | — | — |
| May 27, 2025 | Metz Lawrence F. | See Remarks | Grant(A) | 91K | — | — |
| May 27, 2025 | Metz Lawrence F. | See Remarks | Grant(A) | 11K | — | — |
| May 27, 2025 | Ledbetter Bradford Luke | Chief Executive Officer, Director, 10% Owner | Grant(A) | 906K | — | — |
| May 27, 2025 | Nigro Steven Harold | Director | Grant(A) | 12K | — | — |
| May 27, 2025 | Nigro Steven Harold | Director | Grant(A) | 2K | — | — |
| May 27, 2025 | Nigro Steven Harold | Director | Grant(A) | 600 | — | $0 |
| May 27, 2025 | Ledbetter Terry Lee | Executive Chairman, Director, 10% Owner | Grant(A) | 906K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Kestrel Group Ltd, SEC CIK 0002055116. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under KG and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for KG